| NCT01994096 |
Optimal Dosage of Caspofungin in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT01994096 |
Completed |
University Medical Center Groningen |
2015-10-31 |
| NCT03363841 |
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) |
https://ClinicalTrials.gov/show/NCT03363841 |
Recruiting |
Scynexis, Inc. |
2020-11-15 |
| NCT03203551 |
Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous. |
https://ClinicalTrials.gov/show/NCT03203551 |
Completed |
University of Sao Paulo |
2016-01-01 |
| NCT03140748 |
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation |
https://ClinicalTrials.gov/show/NCT03140748 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2020-06-01 |
| NCT03115073 |
ProF-001_Phase IIa |
https://ClinicalTrials.gov/show/NCT03115073 |
Completed |
ProFem GmbH |
2018-07-30 |
| NCT03090334 |
A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT03090334 |
Recruiting |
University of Bologna |
2020-06-30 |
| NCT03059992 |
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment |
https://ClinicalTrials.gov/show/NCT03059992 |
Recruiting |
Scynexis, Inc. |
2021-09-30 |
| NCT02971007 |
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) |
https://ClinicalTrials.gov/show/NCT02971007 |
Completed |
Matinas BioPharma Nanotechnologies, Inc. |
2017-05-31 |
| NCT02866227 |
TOL-463 Phase 2 Study for Vaginitis |
https://ClinicalTrials.gov/show/NCT02866227 |
Completed |
Toltec Pharmaceuticals, LLC |
2017-06-10 |
| NCT02860845 |
Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections |
https://ClinicalTrials.gov/show/NCT02860845 |
Completed |
Laboratorios Ordesa |
2017-10-16 |
| NCT02818803 |
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic |
https://ClinicalTrials.gov/show/NCT02818803 |
Completed |
University of Sao Paulo |
2016-06-30 |
| NCT02795845 |
Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study |
https://ClinicalTrials.gov/show/NCT02795845 |
Recruiting |
HaEmek Medical Center, Israel |
2021-07-31 |
| NCT02734862 |
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension |
https://ClinicalTrials.gov/show/NCT02734862 |
Completed |
Cidara Therapeutics Inc. |
2019-06-30 |
| NCT02734550 |
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis |
https://ClinicalTrials.gov/show/NCT02734550 |
Completed |
Center for Sepsis Control and Care, Germany |
2019-08-22 |
| NCT02733432 |
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections |
https://ClinicalTrials.gov/show/NCT02733432 |
Completed |
Cidara Therapeutics Inc. |
2016-11-23 |
| NCT02730494 |
Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation |
https://ClinicalTrials.gov/show/NCT02730494 |
Completed |
Biose |
2016-01-31 |
| NCT02679456 |
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02679456 |
Completed |
Scynexis, Inc. |
2016-08-05 |
| NCT02631954 |
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02631954 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-10-31 |
| NCT02493738 |
A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02493738 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2015-10-31 |
| NCT02391532 |
Effect of Probiotic Bacteria on Oral Candida in Frail Elderly |
https://ClinicalTrials.gov/show/NCT02391532 |
Completed |
University of Copenhagen |
2014-03-31 |
| NCT02267382 |
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) |
https://ClinicalTrials.gov/show/NCT02267382 |
Completed |
Viamet |
2016-11-09 |
| NCT02251093 |
Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02251093 |
Completed |
Probionov |
2016-02-29 |
| NCT02248506 |
Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02248506 |
Completed |
Instituto Palacios |
2015-03-31 |
| NCT02244606 |
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT02244606 |
Completed |
Scynexis, Inc. |
2016-06-30 |
| NCT02242695 |
Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02242695 |
Completed |
Medinova AG |
2015-12-31 |
| NCT02184351 |
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis |
https://ClinicalTrials.gov/show/NCT02184351 |
Completed |
Boehringer Ingelheim |
2001-11-30 |
| NCT02180828 |
Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02180828 |
Completed |
Peking University Shenzhen Hospital |
2015-09-30 |
| NCT02180100 |
Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT02180100 |
Completed |
Peking University Shenzhen Hospital |
2014-06-30 |
| NCT02164890 |
Pharmacokinetics of Micafungin in Patients of Intensive Care Units |
https://ClinicalTrials.gov/show/NCT02164890 |
Completed |
University Hospital, Limoges |
2015-12-31 |
| NCT02150655 |
Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women |
https://ClinicalTrials.gov/show/NCT02150655 |
Completed |
Western University, Canada |
2013-09-30 |
| NCT01293643 |
A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) |
https://ClinicalTrials.gov/show/NCT01293643 |
Completed |
Merck Sharp & Dohme Corp. |
2011-01-31 |
| NCT01273922 |
Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida |
https://ClinicalTrials.gov/show/NCT01273922 |
Completed |
NovaDigm Therapeutics, Inc. |
2011-10-31 |
| NCT01926028 |
Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT01926028 |
Completed |
NovaDigm Therapeutics, Inc. |
2015-05-31 |
| NCT01916057 |
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis |
https://ClinicalTrials.gov/show/NCT01916057 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-06-01 |
| NCT01891331 |
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) |
https://ClinicalTrials.gov/show/NCT01891331 |
Completed |
Viamet |
2014-12-31 |
| NCT00835029 |
Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches |
https://ClinicalTrials.gov/show/NCT00835029 |
Completed |
Hadassah Medical Organization |
2012-02-29 |
| NCT01806623 |
The Study Of Fluconazole For Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT01806623 |
Completed |
Pfizer |
2013-11-22 |
| NCT01773876 |
Empirical Antifungal Treatment in ICUS |
https://ClinicalTrials.gov/show/NCT01773876 |
Completed |
University Hospital, Grenoble |
2015-02-28 |
| NCT01666769 |
Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT01666769 |
Completed |
Duke University |
2016-02-02 |
| NCT01497223 |
MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT01497223 |
Completed |
MethylGene Inc. |
2013-04-30 |
| NCT01495039 |
Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients |
https://ClinicalTrials.gov/show/NCT01495039 |
Completed |
Policlinico Hospital |
2009-08-31 |
| NCT01427738 |
Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis |
https://ClinicalTrials.gov/show/NCT01427738 |
Completed |
AIDS Clinical Trials Group |
2012-09-30 |
| NCT04410250 |
Effect of Oral Hygienization in Newborn on Candida Spp Colonization |
https://ClinicalTrials.gov/show/NCT04410250 |
Recruiting |
Federal University of the Valleys of Jequitinhonha and Mucuri |
2020-08-06 |
| NCT03561701 |
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) |
https://ClinicalTrials.gov/show/NCT03561701 |
Active, not recruiting |
Mycovia Pharmaceuticals Inc. |
2020-07-20 |
| NCT04368559 |
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT04368559 |
Recruiting |
Cidara Therapeutics Inc. |
2022-03-31 |
| NCT04292704 |
A Protocol for the Role of Fractional CO2 Laser in Consolidation Treatment of Recurrent Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT04292704 |
Recruiting |
Second Affiliated Hospital of Wenzhou Medical University |
2022-03-31 |
| NCT04148287 |
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris |
https://ClinicalTrials.gov/show/NCT04148287 |
Recruiting |
Amplyx Pharmaceuticals |
2020-05-15 |
| NCT04122560 |
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration |
https://ClinicalTrials.gov/show/NCT04122560 |
Recruiting |
Radboud University |
2020-08-01 |
| NCT04029116 |
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) |
https://ClinicalTrials.gov/show/NCT04029116 |
Recruiting |
Scynexis, Inc. |
2021-06-30 |
| NCT03987620 |
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT03987620 |
Active, not recruiting |
Scynexis, Inc. |
2020-03-31 |
| NCT03975569 |
Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis |
https://ClinicalTrials.gov/show/NCT03975569 |
Completed |
University Hospital, Antwerp |
2017-03-31 |
| NCT03940612 |
Probiotic for Vaginal Candidiasis in Pregnant Women |
https://ClinicalTrials.gov/show/NCT03940612 |
Recruiting |
Universiti Sains Malaysia |
2020-03-24 |
| NCT03906916 |
Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin |
https://ClinicalTrials.gov/show/NCT03906916 |
Recruiting |
Fadoi Foundation, Italy |
2020-01-31 |
| NCT03894839 |
Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species |
https://ClinicalTrials.gov/show/NCT03894839 |
Completed |
Yuzuncu Yıl University |
2018-10-26 |
| NCT03873753 |
Relationship Between Oral Hygiene in Newborns and Candida Spp. |
https://ClinicalTrials.gov/show/NCT03873753 |
Recruiting |
Faculty Sao Leopoldo Mandic Campinas |
2020-07-31 |
| NCT03840616 |
A Study of Oral VT-1161 for the Treatment of Acute Vaginal Candidiasis (Yeast Infection) in Patients With Recurrent Vaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT03840616 |
Recruiting |
Mycovia Pharmaceuticals Inc. |
2020-07-31 |
| NCT03828773 |
PTX3-targeted Antifungal Prophylaxis |
https://ClinicalTrials.gov/show/NCT03828773 |
Recruiting |
Centre Hospitalier Universitaire Vaudois |
2022-07-31 |
| NCT03761628 |
Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT03761628 |
Completed |
Gedea Biotech AB |
2019-12-16 |
| NCT03734991 |
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303) |
https://ClinicalTrials.gov/show/NCT03734991 |
Completed |
Scynexis, Inc. |
2019-08-21 |
| NCT03717623 |
Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants |
https://ClinicalTrials.gov/show/NCT03717623 |
Recruiting |
Melbourne Health |
2020-06-30 |
| NCT03630770 |
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida |
https://ClinicalTrials.gov/show/NCT03630770 |
Recruiting |
Women and Infants Hospital of Rhode Island |
2020-12-31 |
| NCT03538912 |
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers |
https://ClinicalTrials.gov/show/NCT03538912 |
Recruiting |
University Hospital, Lille |
2021-05-31 |
| NCT03468803 |
Influence of Open and Laparoscopic Abdominal Surgery Involving the Intestinal Tract on Serum 1,3-ß-D-Glucan (BDG) Values |
https://ClinicalTrials.gov/show/NCT03468803 |
Completed |
Medical University of Graz |
2019-01-17 |
| NCT03421002 |
Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis |
https://ClinicalTrials.gov/show/NCT03421002 |
Completed |
Astellas Pharma Inc |
2018-04-10 |
| NCT01237795 |
Experimental Denture Pastes |
https://ClinicalTrials.gov/show/NCT01237795 |
Completed |
University of Sao Paulo |
2008-06-30 |
| NCT01237782 |
Efficacy of a Propolis-based Denture Cleanser |
https://ClinicalTrials.gov/show/NCT01237782 |
Completed |
University of Sao Paulo |
2011-06-30 |
| NCT01230814 |
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women |
https://ClinicalTrials.gov/show/NCT01230814 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-08-31 |
| NCT01165320 |
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) |
https://ClinicalTrials.gov/show/NCT01165320 |
Completed |
Merck Sharp & Dohme Corp. |
2013-09-17 |
| NCT01144286 |
Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment |
https://ClinicalTrials.gov/show/NCT01144286 |
Completed |
Ferrer Internacional S.A. |
2011-03-31 |
| NCT01122368 |
A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects |
https://ClinicalTrials.gov/show/NCT01122368 |
Completed |
Astellas Pharma Inc |
2011-12-15 |
| NCT01102387 |
Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections |
https://ClinicalTrials.gov/show/NCT01102387 |
Completed |
Almirall, S.A. |
2011-07-31 |
| NCT01067131 |
Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection |
https://ClinicalTrials.gov/show/NCT01067131 |
Completed |
Pevion Biotech Ltd |
2012-12-31 |
| NCT01039584 |
A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations |
https://ClinicalTrials.gov/show/NCT01039584 |
Completed |
Perrigo Company |
2009-09-30 |
| NCT00895453 |
Monthly Itraconazole Versus Classic Homeopathy for Treatment of Recurrent Vulvovaginal Candidiasis (RVVC) |
https://ClinicalTrials.gov/show/NCT00895453 |
Completed |
Medical University of Vienna |
2006-02-28 |
| NCT02641717 |
Validity of Patient-Collected Wet Mounts |
https://ClinicalTrials.gov/show/NCT02641717 |
Completed |
The University of Texas Health Science Center at San Antonio |
2016-07-31 |
| NCT01769339 |
An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis |
https://ClinicalTrials.gov/show/NCT01769339 |
Completed |
Janssen Pharmaceutica |
2009-06-30 |
| NCT03562156 |
A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) |
https://ClinicalTrials.gov/show/NCT03562156 |
Active, not recruiting |
Mycovia Pharmaceuticals Inc. |
2020-07-20 |
| NCT03253094 |
An Active-Controlled, Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT03253094 |
Completed |
Scynexis, Inc. |
2018-05-04 |
| NCT01447407 |
Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine |
https://ClinicalTrials.gov/show/NCT01447407 |
Completed |
NovaDigm Therapeutics, Inc. |
2012-03-31 |
| NCT00803738 |
Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT00803738 |
Completed |
Perrigo Company |
2003-12-31 |
| NCT03024502 |
Patients With Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT03024502 |
Recruiting |
University of Sao Paulo |
2020-01-31 |
| NCT02629419 |
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis |
https://ClinicalTrials.gov/show/NCT02629419 |
Active, not recruiting |
Matinas BioPharma Nanotechnologies, Inc. |
2021-01-31 |
| NCT03667690 |
Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT03667690 |
Recruiting |
Cidara Therapeutics Inc. |
2020-09-30 |
| NCT01743690 |
The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus |
https://ClinicalTrials.gov/show/NCT01743690 |
Completed |
University of Copenhagen |
2015-12-31 |
| NCT00784368 |
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection |
https://ClinicalTrials.gov/show/NCT00784368 |
Completed |
Janssen Pharmaceutical K.K. |
2009-04-30 |
| NCT00768794 |
Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT00768794 |
Completed |
Summa Health System |
2010-03-31 |
| NCT00761267 |
Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00761267 |
Completed |
Pfizer |
2018-02-28 |
| NCT00755053 |
Comparative Efficacy of Ovule vs Tablet |
https://ClinicalTrials.gov/show/NCT00755053 |
Completed |
Bayer |
2009-05-31 |
| NCT00739934 |
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection |
https://ClinicalTrials.gov/show/NCT00739934 |
Completed |
Pfizer |
2009-10-31 |
| NCT00734539 |
Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight |
https://ClinicalTrials.gov/show/NCT00734539 |
Completed |
Duke University |
2011-12-31 |
| NCT00689338 |
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study |
https://ClinicalTrials.gov/show/NCT00689338 |
Completed |
Pfizer |
2010-05-31 |
| NCT00672841 |
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients |
https://ClinicalTrials.gov/show/NCT00672841 |
Completed |
Duke University |
2010-12-31 |
| NCT00670657 |
CRITIC - Treatment of Candidemia and Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00670657 |
Completed |
Gilead Sciences |
2008-12-31 |
| NCT00666185 |
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis |
https://ClinicalTrials.gov/show/NCT00666185 |
Completed |
Astellas Pharma Inc |
2004-02-29 |
| NCT00665639 |
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis |
https://ClinicalTrials.gov/show/NCT00665639 |
Completed |
Astellas Pharma Inc |
2004-12-31 |
| NCT00659971 |
Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis |
https://ClinicalTrials.gov/show/NCT00659971 |
Completed |
Pacgen Biopharmaceuticals Corporation |
2008-06-30 |
| NCT00647907 |
A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections |
https://ClinicalTrials.gov/show/NCT00647907 |
Completed |
Pfizer |
NA |
| NCT00635648 |
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) |
https://ClinicalTrials.gov/show/NCT00635648 |
Completed |
Merck Sharp & Dohme Corp. |
2011-05-31 |
| NCT00608335 |
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug |
https://ClinicalTrials.gov/show/NCT00608335 |
Completed |
Astellas Pharma Inc |
2011-09-08 |
| NCT00607763 |
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug |
https://ClinicalTrials.gov/show/NCT00607763 |
Completed |
Astellas Pharma Inc |
2009-10-31 |
| NCT00553137 |
Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania |
https://ClinicalTrials.gov/show/NCT00553137 |
Completed |
Netherlands Organisation for Scientific Research |
2007-12-31 |
| NCT00548262 |
This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00548262 |
Completed |
Pfizer |
2009-10-31 |
| NCT00520234 |
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) |
https://ClinicalTrials.gov/show/NCT00520234 |
Completed |
Mycoses Study Group |
2010-03-31 |
| NCT00496197 |
Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00496197 |
Completed |
Pfizer |
2010-06-30 |
| NCT00413218 |
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections |
https://ClinicalTrials.gov/show/NCT00413218 |
Completed |
Astellas Pharma Inc |
2015-03-03 |
| NCT00390780 |
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients |
https://ClinicalTrials.gov/show/NCT00390780 |
Completed |
Onxeo |
2007-12-31 |
| NCT00353561 |
Diabetes Mellitus and Vulvovaginal Candidiasis |
https://ClinicalTrials.gov/show/NCT00353561 |
Completed |
Indian Council of Medical Research |
2006-04-30 |
| NCT00330395 |
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) |
https://ClinicalTrials.gov/show/NCT00330395 |
Completed |
Merck Sharp & Dohme Corp. |
2006-10-31 |
| NCT00313131 |
Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments |
https://ClinicalTrials.gov/show/NCT00313131 |
Completed |
Université de Sherbrooke |
NA |
| NCT00250432 |
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00250432 |
Completed |
Merck Sharp & Dohme Corp. |
2008-01-31 |
| NCT00194324 |
Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina |
https://ClinicalTrials.gov/show/NCT00194324 |
Completed |
University of Pennsylvania |
NA |
| NCT00189709 |
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia |
https://ClinicalTrials.gov/show/NCT00189709 |
Completed |
Astellas Pharma Inc |
2006-07-31 |
| NCT00163111 |
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. |
https://ClinicalTrials.gov/show/NCT00163111 |
Completed |
Pfizer |
NA |
| NCT00128323 |
A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis |
https://ClinicalTrials.gov/show/NCT00128323 |
Completed |
University of Malawi College of Medicine |
NA |
| NCT00106288 |
Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia |
https://ClinicalTrials.gov/show/NCT00106288 |
Completed |
Astellas Pharma Inc |
2005-12-31 |
| NCT00105144 |
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia |
https://ClinicalTrials.gov/show/NCT00105144 |
Completed |
Astellas Pharma Inc |
2006-04-30 |
| NCT00099775 |
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units |
https://ClinicalTrials.gov/show/NCT00099775 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00083343 |
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) |
https://ClinicalTrials.gov/show/NCT00083343 |
Completed |
Merck Sharp & Dohme Corp. |
2006-02-28 |
| NCT00082524 |
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) |
https://ClinicalTrials.gov/show/NCT00082524 |
Completed |
Merck Sharp & Dohme Corp. |
2007-07-31 |
| NCT00058682 |
Anidulafungin Versus Fluconazole in the Treatment of Candidemia |
https://ClinicalTrials.gov/show/NCT00058682 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00056368 |
The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00056368 |
Completed |
Pfizer |
NA |
| NCT00797420 |
Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers |
https://ClinicalTrials.gov/show/NCT00797420 |
Completed |
Duke University |
2010-01-31 |
| NCT00005912 |
Voriconazole to Prevent Systemic Fungal Infections in Children |
https://ClinicalTrials.gov/show/NCT00005912 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001937 |
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients |
https://ClinicalTrials.gov/show/NCT00001937 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001812 |
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 |
https://ClinicalTrials.gov/show/NCT00001812 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001810 |
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
https://ClinicalTrials.gov/show/NCT00001810 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041704 |
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) |
https://ClinicalTrials.gov/show/NCT00041704 |
Completed |
Pfizer |
NA |
| NCT00001542 |
Fluconazole Prophylaxis of Thrush in AIDS |
https://ClinicalTrials.gov/show/NCT00001542 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00037219 |
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. |
https://ClinicalTrials.gov/show/NCT00037219 |
Completed |
Pfizer |
NA |
| NCT00036179 |
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis |
https://ClinicalTrials.gov/show/NCT00036179 |
Completed |
Astellas Pharma Inc |
2002-01-27 |
| NCT00005921 |
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis |
https://ClinicalTrials.gov/show/NCT00005921 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002446 |
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT00002446 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002431 |
The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00002431 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002399 |
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients |
https://ClinicalTrials.gov/show/NCT00002399 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002394 |
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment |
https://ClinicalTrials.gov/show/NCT00002394 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002341 |
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole |
https://ClinicalTrials.gov/show/NCT00002341 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002339 |
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems |
https://ClinicalTrials.gov/show/NCT00002339 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002304 |
A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems |
https://ClinicalTrials.gov/show/NCT00002304 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002293 |
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes |
https://ClinicalTrials.gov/show/NCT00002293 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00002282 |
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002282 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002133 |
An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. |
https://ClinicalTrials.gov/show/NCT00002133 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002132 |
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis. |
https://ClinicalTrials.gov/show/NCT00002132 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002112 |
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00002112 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002057 |
Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC |
https://ClinicalTrials.gov/show/NCT00002057 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00002041 |
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients |
https://ClinicalTrials.gov/show/NCT00002041 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00002038 |
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy |
https://ClinicalTrials.gov/show/NCT00002038 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001107 |
Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants |
https://ClinicalTrials.gov/show/NCT00001107 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001065 |
A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole |
https://ClinicalTrials.gov/show/NCT00001065 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000951 |
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush |
https://ClinicalTrials.gov/show/NCT00000951 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000788 |
A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of Methadone |
https://ClinicalTrials.gov/show/NCT00000788 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000744 |
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women |
https://ClinicalTrials.gov/show/NCT00000744 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000676 |
Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) |
https://ClinicalTrials.gov/show/NCT00000676 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |